Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

dicentra Helps NNB Nutrition Achieve Self-Affirmed GRAS (Generally Recognized as Safe) Status for Its Antioxidant MitoPrime® And Exercise Factor MitoBurn®


News provided by

dicentra

Jun 09, 2022, 11:00 ET

Share this article

Share toX

Share this article

Share toX


Leading contract research organization and professional consulting firm dicentra is proud to announce that their valued client, NNB Nutrition, has successfully achieved self-affirmed GRAS (Generally Recognized as Safe) status for their products MitoPrime® and MitoBurn®.

TORONTO, June 9, 2022 /PRNewswire-PRWeb/ -- Leading contract research organization and professional consulting firm dicentra is proud to announce that their valued client, NNB Nutrition, has successfully achieved self-affirmed GRAS (Generally Recognized as Safe) status for their products MitoPrime® and MitoBurn®.

NNB's MitoPrime® (L-ergothioneine) is a derivative of the α-amino acid histidine, an essential amino acid. As such, L-ergothioneine is not readily synthesized in the body and is acquired exclusively through diet. L-ergothioneine, NNB's patented, highly enhanced form of L-ergothioneine, is known in the scientific community as the "longevity vitamin".

u201cWe are very proud to have contributed to NNBu2019s successful Self-Affirmed GRAS status for their two products MitoPrimeu00ae and MitoBurnu00ae,u201d said Dr. Karol Wojewnik, Partner, dicentra.

Post this

It is an antioxidant and research suggests that it has potent cytoprotectant properties. With antioxidation capabilities stronger than any other product known to mankind, this unique ingredient is available in multiple formats, including topical cosmetic applications.
Some topical application claims Mitoprime® can make:

  • Prevents telomeres Shortening
  • Reverses Sun Damage
  • Improves Smoothness & Luminosity
  • Reduction in Pores
  • Protects Collagen
  • Evens SkinTone
  • Increased Elasticity
  • Repairs Skin Mitochondrial Damage
  • Protects Skin cell Membranes
  • Removes Wrinkle-causing cells
  • Strengthens the Skin Microbes

MitoBurn® (β-aminoisobutyric Acid or L-BAIBA) is an exercise factor released during exercise, that is thought to play a critical role in weight management, by initiating the browning of white fat and improving insulin sensitivity.

NNB, an innovative technological enterprise dedicated to research, development, production, and sales of innovative nutrient raw materials, received GRAS status for both MitoPrime® and MitoBurn® in 2021. In June GRAS status was achieved for MitoPrime® on the basis that the ingredient L-ergothioneine is a derivative of histidine, exists naturally in nature, and can be obtained through diet. In September GRAS status was achieved for MitoBurn® on the basis that beta-aminoisobutyric acid is a known catabolite of thymine and valine metabolism in mammals.

dicentra provided an initial analysis of GRAS requirements, conducted literature searches, evaluated published safety data, prepared independent GRAS conclusions, and compiled the self-affirmed GRAS dossiers for NNB Nutrition. dicentra's expertise was indispensable in demonstrating that both MitoPrime® and MitoBurn® are safe ingredients.

"We are very proud to have contributed to NNB's successful Self-Affirmed GRAS status for their two products MitoPrime® and MitoBurn®," said Dr. Karol Wojewnik, Partner, dicentra. "We value their passion and their dedication to providing innovative products that improve the lives of their end consumers."

"We are not simply a manufacturer of supplements, what we aim for is bringing completely innovative ingredient ideas from the brain to your life," said Kylin Liao, the founder of NNB. "All the members of the NNB team keep this mission in mind and pursue it unremittingly through the process of concept creation, idea implementation via technology R&D, clinical study, patent filing, flexible manufacturing and marketing. Compared to fancy benefits claims which don't have any clinical support existing in the industry, NNB values technology a lot more, which leads us to achieve rapid development in R&D along with a good reputation in the industry during the past recent years."

About dicentra
dicentra is a full-service Contract Research Organization (CRO) and professional consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the global life sciences and food industries. We evaluate, implement, and provide all the necessary support for products and operations to gain market access and build confidence in your brand. We achieve this through our four business divisions: Life Sciences, Food Safety & Quality, Global Certifications, and Clinical Trials. Since our inception in 2002, we have completed over 24,000 projects and serviced over 1,400 companies internationally.

dicentra is headquartered in Toronto, Ontario. For more information, visit http://www.dicentra.com.

About NNB Nutrition
NNB Nutrition is an innovative technology enterprise dedicated to research, development, production and sales of innovative nutrient raw materials. In cooperation with world-class outstanding scientists, NNB has built a top international R&D team in the industry, using customized processing mode to create and produce new raw materials for global partners. Nowadays, with the vigorous development of the health industry, NNB always insists on taking technological innovation as its core product, fully guaranteeing product quality and devoting itself to creating ingredients for human health.

NNB is headquartered in Nanjing, China with subsidiaries in California, the US, and Shanghai, Hong Kong in China with an elite global team of over 100 scientists from more than 10 countries. For more information, visit https://nnbnutrition.com/.

Media Contact

Kory Punkkinen, dicentra, 1-866-647-3279, [email protected]

Josie Wang, NNB Nutrition, +86-133 5770 2967, [email protected]

SOURCE dicentra

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.